Delivery Order SPE2DB22D2108-SPE2DB25FU5WF
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 12, 2025, for the supply of Mounjaro 7.5 mg/0.5 mL pen injections valued at $5,624.52 with a completion date of September 15, 2025. This is a firm fixed-price delivery order with no set-aside designation, issued under a competitive procurement process. The order will be fulfilled from the vendor's location in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters as...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 15, 2025, for the supply of Mounjaro 7.5 mg/0.5 mL pen injections, with a ceiling value of $1,738.69 and an ultimate completion date of August 18, 2025. The contract is a firm fixed-price delivery order with no set-aside designation, indicating it was competitively awarded. The place of performance is AmerisourceBergen's Corporate Office location in Conshohocken, Pennsylvania. This delivery order is...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 11, 2025, for the supply of Mounjaro 10 mg/0.5 ml pen injections valued at $7,989.68. This competitively awarded, firm fixed-price delivery order is scheduled for completion by September 12, 2025, with performance taking place at AmerisourceBergen's Conshohocken, Pennsylvania facility. The contract carries no set-aside designation, reflecting the contractor's demonstrated capability to compete in...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 10, 2025, for the supply of Mounjaro 15 mg/0.5 ml pen injections with a ceiling value of $1,088.36. This competitively awarded, firm fixed-price delivery order is scheduled for completion by September 11, 2025, and will be fulfilled from the vendor's location in Conshohocken, Pennsylvania. The contract carries no set-aside designation, reflecting AmerisourceBergen's capability to compete in open...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 23, 2025, for the supply of Mounjaro 7.5 mg/0.5 ml pen injections with a ceiling value of $4,140.74. This is a firm fixed price delivery order with an ultimate completion date of July 24, 2025, and represents a non-competitive set-aside award. The place of performance is listed as AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 6, 2025, for the supply of Mounjaro 5 mg/0.5 mL pen injections with a contract ceiling value of $47,883.19. This competitively awarded, non-set-aside delivery order utilizes firm fixed pricing and is scheduled for completion by August 7, 2025. The pharmaceutical product will be delivered to the place of performance in Conshohocken, Pennsylvania, AmerisourceBergen's corporate headquarters location. This...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 7, 2025, for the supply of Mounjaro 7.5 mg/0.5 ml pen injections with a ceiling value of $20,300.82. This is a firm fixed-price delivery order with no set-aside designation, classified as a competitive award. The order is scheduled for ultimate completion by August 8, 2025, with performance taking place at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. As a major...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $8,523.07 on August 8, 2025, for Mounjaro 7.5 mg/0.5 ml pen injections. This contract represents a firm fixed price delivery order with no set-aside designation, issued competitively under the agency's pharmaceutical procurement framework. The order is scheduled for completion by August 11, 2025, and will be fulfilled from the contractor's Conshohocken, Pennsylvania facility. This delivery order is issued...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 14, 2025, for the supply of Mounjaro 10 mg/0.5 ml pen injections with a ceiling value of $1,738.43. This competitively awarded, firm fixed-price delivery order is scheduled for completion by July 15, 2025, and will be fulfilled from the contractor's Conshohocken, Pennsylvania facility. The award carries no set-aside designation, indicating it was open to all qualified vendors in federal competition. This...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 17, 2025, for the supply of Mounjaro 15 mg/0.5 ml pen injections with a ceiling value of $1,904.63. This competitively awarded, firm fixed-price delivery order is set to be completed by July 18, 2025, and will be fulfilled from the vendor's facility in Conshohocken, Pennsylvania. The award represents a continuation of pharmaceutical supply services under AmerisourceBergen's broader contract vehicle...
- SPE2DB22D2108Indefinite Delivery Contract
- SPE2DB22D2108-SPE2DB25FU5WFDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 17, 2025, for the supply of Mounjaro 7.5 mg/0.5 ml pen injections with a ceiling value of $11,387.60. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded to support federal medical procurement needs. The order is set to be completed by September 18, 2025, and will be fulfilled from the vendor's corporate office location in Conshohocken, Pennsylvania. This delivery order falls under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999.99 million and extending through December 2026. As a major pharmaceutical distributor, AmerisourceBergen supplies a comprehensive range of medications and medical supplies to military and federal healthcare systems. The Mounjaro delivery supports the company's established portfolio of pharmaceutical products, which includes diabetes medications, specialty treatments, and other critical healthcare commodities required across the Defense Health Agency and related federal medical supply chains.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $11.4k | 9/17/25 |